Institute of Organic Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Łódź, Poland.
Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wrocław, Poland.
Peptides. 2020 Oct;132:170365. doi: 10.1016/j.peptides.2020.170365. Epub 2020 Jul 2.
The synthesis of new analogues of cyclolinopeptide A (CLA) and their linear precursors modified with (R)- and (S)-4-methylpseudoproline in the Pro-Pro fragment are presented. The peptides were tested in comparison with cyclosporine A (CsA) in concanavalin A (Con A) and pokeweed mitogen (PWM)-induced mouse splenocyte proliferation and in secondary humoral immune response in vitro to sheep erythrocytes (SRBC). Their effects on expression of selected signaling molecules in the Jurkat T cell line were also determined. In addition, the structural features of the peptides, applying nuclear magnetic resonance and circular dichroism, were analyzed. The results showed that only peptides 7 and 8 modified with (R)-4-methylpseudoproline residue (c(Leu-Val-(R)-(αMe)Ser(ΨPro)-Pro-Phe-Phe-Leu-Ile-Ile) and c(Leu-Val-Pro-(R)-(αMe)Ser(ΨPro)-Phe-Phe-Leu-Ile-Ile), respectively) strongly suppressed mitogen-induced splenocyte proliferation and the humoral immune response, with peptide 8 being more potent. Likewise, peptide 8 more strongly elevated expression of Fas, a proapoptotic signaling molecule in Jurkat cells. We postulate that the increased biological activity of peptide 8, compared to the parent molecule and other studied peptides, resulted from its more flexible structure, found on the basis of both CD and NMR studies. CD and NMR spectra showed that replacement of Pro by (R)-(αMe)Ser(¬Pro) caused much greater conformational changes than the same replacement of the Pro residue. Such a modification could lead to increased conformational freedom of peptide 8, resulting in a greater ability to adopt a more compact structure, better suited to its putative receptor. In conclusion, peptide 8 is a potent immune suppressor which may find application in controlling immune disorders.
呈现了新型环缩氨酸 A (CLA) 类似物及其在 Pro-Pro 片段中用 (R)-和 (S)-4-甲基脯氨酸修饰的线性前体的合成。与环孢素 A (CsA) 相比,这些肽在伴刀豆球蛋白 A (Con A) 和美洲商陆丝裂原 (PWM) 诱导的小鼠脾细胞增殖以及体外绵羊红细胞 (SRBC) 的二次体液免疫反应中进行了测试。还确定了它们对 Jurkat T 细胞系中选定信号分子表达的影响。此外,还应用核磁共振和圆二色性分析了肽的结构特征。结果表明,只有用 (R)-4-甲基脯氨酸残基修饰的肽 7 和 8(c(Leu-Val-(R)-(αMe)Ser(ΨPro)-Pro-Phe-Phe-Leu-Ile-Ile) 和 c(Leu-Val-Pro-(R)-(αMe)Ser(ΨPro)-Phe-Phe-Leu-Ile-Ile))强烈抑制了有丝分裂原诱导的脾细胞增殖和体液免疫反应,而肽 8 更为有效。同样,肽 8 更强烈地提高了 Jurkat 细胞中促凋亡信号分子 Fas 的表达。我们推测,与母体分子和其他研究肽相比,肽 8 的生物活性增加是由于其结构更具灵活性,这是基于 CD 和 NMR 研究得出的。CD 和 NMR 谱表明,用 (R)-(αMe)Ser(¬Pro)取代 Pro 会引起比相同的 Pro 残基取代更大的构象变化。这种修饰可能会导致肽 8 构象自由度增加,从而使其更能采用更紧凑的结构,更适合其假定的受体。总之,肽 8 是一种有效的免疫抑制剂,可能在控制免疫紊乱方面有应用。